No Data
No Data
jiangzhong pharmaceutical (600750.SH) plans to distribute 0.5 yuan per share for the half year, ex-dividend and ex-dividend on October 10th.
Jiangzhong Pharmaceutical (600750.SH) announced that the company plans to distribute cash dividends of 0.5 yuan per share for the first half of 2024...
Here's Why Jiang Zhong PharmaceuticalLtd (SHSE:600750) Has Caught The Eye Of Investors
Jiangzhong Pharmaceutical's H1 Profit Rises 9%, Revenue Slides 8%
Summary of the semi-annual report of jiangzhong pharmaceutical in 2024
Jiangzhong Pharmaceutical Semi-Annual Report 2024
Chinares Pharma (03320.HK): jiangzhong pharmaceutical's net profit attributable to shareholders in the first half of the year was 0.489 billion yuan, a year-on-year increase of 8.66%.
On August 21, Chinares Pharma (03320.HK) announced that Jiangzhong Pharmaceutical's shares are listed on the Shanghai Stock Exchange. As of the date of this announcement, Jiangzhong Pharmaceutical is held by Chinares Medicine Group Limited (the 'Company'), along with its subsidiary, Chinares Jiangzhong Pharmaceutical Group Co., Ltd., and holds approximately 43.09% of the equity. The Group actually controls 26.09% of Jiangzhong Pharmaceutical, which is accounted for as a subsidiary of the Company. Jiangzhong Pharmaceutical's unaudited financial performance for the six months ending June 30, 2024. Jiangzhong Pharmaceutical achieved a revenue of 21 million in the first half of 2024.
No Data
No Data